We're building DxMultiomics to be The Central Nexus of Biotech Intelligence. To ensure a seamless experience and continuous improvement, we utilize website analytics. These tools help us monitor site performance, understand how users navigate the platform, and identify opportunities to make your research journey more efficient. We handle this data with the utmost respect for your privacy, and you can choose what works best for you.
Cyrano Therapeutics is a private, venture-backed clinical stage regenerative medicine company. The Company is working diligently to develop therapies for people struggling with the loss of smell and taste. Cyrano is working to advance the development of CYR-064 as a potential first-ever treatment for post-viral smell loss (hyposmia)